课题基金 / 基金详情

OPEN LABEL EXTENSION OF PROTOCOL AALS 001

OPEN LABEL EXTENSION OF PROTOCOL AALS 001
协议 AALS 001 的开放标签扩展
批准号:
7625790
负责人:
ZACHARY SIMMONS
金额:
$1.56万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2008-03-31

项目摘要

项目成果

ZACHARY SIMMONS的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this open label study is to assess the long-term safety and tolerability of arimoclomol in patients with ALS who have completed 12 weeks of treatment and the week 16 follow-up visit of the AALS-001 study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A MULTICENTER STUDY FOR THE VALIDATION OF ALS BIOMARKERS
EARLY TREATMENT OF ALS W NUTRITION & NON-INVASIVE POSITIVE PRESSURE VENTILATION
ALS NUTRITION
MULTICENTER, STUDY OF ARIMOCLOMOL IN AMYOTROPHIC LATERAL SCLEROSIS (ALS)